Nationwide, the US spent $291 billion on prescription drugs over the last 12 months. Of that more than $80 billion derives not from the cost of meds, but was invested in the distribution infrastructure. Rexanto introduces software platform technologies to reduce infrastructure costs in the prescription drugs supply chain.

Meaningful change

40 million US residents covered by Medicare's prescription drug program, are faced with a coverage gap, often called the "donut-hole". Consumers in the coverage gap pay entire drug costs and they are fearful both of entering the donut hole and of costs in the donut hole.

How far would you drive to get gas for $1? Probably more so, if you drove a large SUV, than if you drove a hybrid. Rexanto's solution is immediately appealing to 18M "Hi-Spend" seniors that are responsible for $61B (21%) of US prescription drug expenses.

How far would you drive to get green gas for $1? Rexanto's solution is also appealing to consumers who are concerned whether meds are being taken correctly. Rexanto's solution is an appealing alternate to weekly pill-minders for 17 million "unpaid care-givers" – family members who travel weekly to visit and provide care for non-cohabitating senior loved ones.

Technology to transform the industry

Rexanto provides SaaS based enterprise solutions to pharmacies to address infrastructure costs. Addressing infrastructure costs makes a $9B impact to the $61B spent by Hi-Spend seniors at US pharmacies.

Addressing infrastructure costs is also the trigger function to migrate the pharmacy industry to a SaaS platform. [SalesForce penetrated the market as a CRM solution provider, but is today established as the leading SaaS application platform provider]. Rexanto migrates the pharmacy industry to SaaS platforms, and will drive application proliferation and application interoperability for pharmacies under the security of Rexanto proprietary HIPAA technologies.